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The health inequalities often experienced by people with intellectual 
disabilities have been known of for many years. Poorer outcomes 
are often associated with late diagnosis, misdiagnosis, variations in 
access to appropriate investigations and treatment, and lack of robust 
implementation of reasonable adjustments. Epilepsy is common in 
people with intellectual disabilities, and it increases in prevalence as 
the level of disability increases. It is a serious comorbidity, in which 
behavioural and psychiatric presentations are common. Epilepsy is 
also a condition which often falls into the mind–body gap in terms of 
the way clinicians and services respond. 
This tiered approach to a training and competency framework, devel-
oped for psychiatrists working in the field of intellectual disabilities, 
sets out the profession’s commitment to deliver a clinical infrastructure 
that can support care pathways, raise standards of care delivery and, 
ultimately, improve patient outcomes. 
Jean O’Hara FRCPsych
National Clinical Director for learning (intellectual) disabilities 
NHS England
31 March 2017
People with intellectual disability (ID) are more likely to have 
comorbid health problems, particularly epileptic seizures. 
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Epilepsy and its treatment not only influence behaviour, but also 
affect long-term mental and physical healthcare outcomes in 
this group. Therefore, awareness and management of epilepsy 
is essential for any psychiatrist working with people with ID.
There is a lack of clarity on training standards, pathways to 
achieve competency and expected roles. This is part of a larger 
problem: care pathways for people with ID and epilepsy are 
poorly defined, poorly regulated and poorly governed.
This initiative from the Royal College of Psychiatrists’ Faculty 
of Psychiatry of Intellectual Disability proposes a competency 
strategy for its members to benchmark their competencies, 
develop them as required, and better support their patients 
with ID and epilepsy.
A tiered model (Bronze, Silver and Gold) is proposed to evidence 
the competencies of a psychiatrist working with people with ID. 
Each of these categories is benchmarked to National Institute 
for Health and Care Excellence (NICE) outcome indicators for 
epilepsy and Scottish Intercollegiate Guidelines Network (SIGN) 
guidance. The tired model is a continuum rather than a definitive 
categorical structure. The expectation is that psychiatrists 
working with people with ID or training in the specialty of ID 
will, at the minimum, satisfy the criteria of a Bronze grade.
The Bronze grade requires competency in delivering four of the 
nine NICE outcome measures. The focus is on basic management 
of epilepsy, including awareness and mitigation of direct and 
indirect risk issues, non-complex diagnosis and treatment, 
and effects and side-effects of epilepsy treatments. Additional 
‘desirable’ competencies include awareness of the relevant local 
pathways for a person with ID to access specialist epilepsy care, 
and joint working with specialist services.
Executive summary
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The Silver grade requires psychiatrists to be familiar with NICE 
and SIGN guidelines and to deliver on all nine outcomes. The 
focus is on managing most people with ID and epilepsy directly. 
In complex cases, a recognised back-up system of a neurology 
service or other specialist epilepsy service is in place. There is 
an expectation that the ID services will have access to other 
specialist clinicians, such as an epilepsy liaison nurse and 
appropriate investigations services.
At the Gold grade, psychiatrists are likely to work very closely with 
tertiary care specialists. They will have a level of knowledge and 
skills in epilepsy which go beyond the NICE or SIGN guidance, 
and be able to manage all aspects of epilepsy diagnosis and 
treatment. All NICE quality standards will be applicable and these 
psychiatrists are likely to be involved in education and standard-
setting for people with ID and epilepsy at a national level.
Clinical vignettes have been provided to aid understanding 
of the Bronze, Silver and Gold models and their application 
to psychiatrists and their local services, recognising that 
psychiatrists may have a mixture of skills which sit between 
categories. The strategy aims to engage such psychiatrists to 
consider other relevant skill sets which can support them to 
move forward definitively. It is hoped that the template will serve 
as a pathway for those currently at a Bronze level to move to 
Silver and Gold.
A structured pathway for epilepsy competency needs to be 
provided for psychiatry trainees in ID. An evidence-based 
framework, using the Learning Disabilities Core Skills Education 
and Training Framework commissioned by the Department of 
Health, is postulated to help incorporate epilepsy training into 
the curriculum. 
Other suggestions include a tool modelled on the Department 
of Health’s Green Light Toolkit for mental health for self-audit 
and assessment of local epilepsy services for people with ID, 
and for identifying what the local commissioning board should 
be aiming to achieve, including quality outcomes.
An Appendix is provided as a separate document, which includes 
a list and samples of currently used good practice tools relevant 
to people with ID and epilepsy, as well as a ‘frequently asked 
questions’ section on Epilepsy that would be of particular use 
to patients, families and carers.
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Introduction
Psychiatrists working with people with intellectual disability (ID; also 
known as learning disability) are, by definition, experts in comorbidity. 
This is most clearly seen in the case of mental illness and ID, and, to 
a lesser extent, when working with challenging behaviour. Epilepsy, 
despite being the most frequent chronic serious comorbidity in people 
with ID, has undoubtedly suffered from a lack of clarity regarding 
exactly what role the psychiatrist should have. This has led to some 
variation in the role of ID services, and great variation in psychiatrists’ 
views of their own role. This, as evidenced by a recent International 
League Against Epilepsy (ILAE) survey – discussed at length on pp. 
12–13 of this report – has added to a general confusion as to where 
patients with ID and epilepsy stand in term of care delivery. To put it 
simply, who cares – the general practitioner (GP), the psychiatrist or 
the neurologist? However, existential debates by physicians on their 
care role do not help the patients. Patients should see professionals 
who have the skills and capacity to manage their illness to a high 
standard. Access to such care should be unambiguously signposted.
This long-awaited document offers an important step towards clarify-
ing the role of the psychiatrist in ID in the management of epilepsy. The 
proposed tiered system of professional competency gives psychiatrists 
the option to identify their role in care provision and ensures a frame-
work for training. It provides a structure from which a competency 
evaluation can be developed. The vision should be for all psychiatrists 
working with people with ID to have training and certification to one of 
the three levels of competency (Bronze, Silver and Gold). This is not an 
unreasonable aim: the Royal College of Paediatricians has achieved 
a similar standard with their paediatric epilepsy training courses. 
Our College has an opportunity to lead the training of psychiatrists 
in epilepsy competency, and thus to raise standards and save lives. 
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Background
Epilepsy is a common condition in people with ID. The complex needs 
of people with ID and epilepsy – particularly in terms of physical and 
behavioural comorbidity – mean that they are frequent users of ID 
services. This complexity can also lead to difficulties in the deliv-
ery of neurological care in traditional settings. Within the UK, the 
strong presence of ID psychiatry with an interest in epilepsy has led 
to psychiatrists and ID teams managing the epilepsy alongside tradi-
tional neurological care. This is because there is a significant overlap 
between ID, psychiatric symptoms and epilepsy. The management 
of epilepsy by psychiatrists working with people with ID, although 
common, is not universal. Unfortunately, owing to this approach not 
being uniform, patients across the UK can sometimes receive frag-
mented care, depending on where they live – no one is certain as to 
who has primary responsibility. There is a postcode lottery, leading to 
difficulties for patients and carers in navigating the system. In many 
places, there are expectations that neurology services will deliver 
epilepsy care. However, neurology does not equate to epilepsy, as 
neurologists – like psychiatrists – subspecialise into diverse domains, 
and thus not all neurologists are epilepsy specialists. In services such 
as neurology, it is possible that the ID-specific elements of epilepsy – 
for example, environmental risk assessments, understanding of mental 
and behavioural side-effects, and person-centred communication 
– will not be formally undertaken. There is a growing expectation 
on the part of patients, their families and other stakeholders that 
psychiatrists and services working with people with ID should have 
the necessary skills to manage epilepsy. However, the requirements 
associated with this are not always clear. There is no clearly defined 
requirement for ongoing training in managing the condition once a 
psychiatrist is appointed to a consultant or career grade post.
The Royal College of Psychiatrists’ Faculty of Psychiatry of Intellectual 
Disability have a role in setting standards for the profession. This report 
highlights the current problems encountered by people with ID who 
also have epilepsy across the UK, and provides recommendations to 
address these problems. We also aim to define the potential breadth 
of roles of ID psychiatry in managing epilepsy and thus help in the 




ID is characterised by impairment of skills manifested during the 
developmental period which contributes to the individual’s overall 
level of intelligence – that is, cognitive, language, motor and social 
abilities. According to the ICD-10, which is the most widely used 
classification system, the levels of severity of ID can be divided, on 
the basis of IQ, into mild (IQ 50–69), moderate (IQ 35-49), severe (IQ 
20–34) and profound (IQ less than 20) (WHO, 1992). Among those 
with a diagnosis of ID, about 85% have mild ID, 10% have moderate 
ID, 4% have severe ID, and around 1% have profound ID. Life expec-
tancy in mild ID groups is no different from the general population 
(Patja et al, 2000). However, life expectancy is reduced in people with 
moderate or higher levels of ID, with moderate to profound IDs related 
to mortality three times higher than standardised rates (Tyrer et al, 
2007). There is significantly higher mental (Harris, 2006) and physical 
(van Schrojenstein Lantman-De Valk et al, 2000) comorbidity in ID 
populations when compared with the general population. Again, the 
trend of comorbidities is related to the intensity of ID.
Epilepsy 
Epilepsy is the propensity to have recurrent seizures. Seizures are 
transient behavioural, emotional, motor or sensory symptoms or 
signs, with or without an alteration in consciousness, due to abnor-
mal excessive or synchronous neural activity (Fisher et al, 2014). The 
ILAE state that epilepsy is a disease of the brain defined by any of 
the following conditions:
 z at least two unprovoked (or reflex) seizures that are more than 
24 h apart
 z one unprovoked (or reflex) seizure and a probability of further 
seizures similar to the general recurrence risk (at least 60%) 
after two unprovoked seizures occurring, over the next 10 years 
 z diagnosis of an epilepsy syndrome (Fisher et al, 2014). 
Up-to-date details about seizure types and classifications can be 
accessed via the ILAE website (http://www.ilae.org/Visitors/Centre/
Definition_Class.cfm). 
Current situation 9
In the general adult population, epilepsy is the second most common 
chronic neurological disorder after stroke (Prasher & Kerr, 2016). 
According to the National Institute for Health and Care Excellence 
(NICE, 2012), an accurate estimate of incidence and prevalence is 
difficult to obtain because of the difficulty in identifying and defin-
ing people who may have epilepsy. Epilepsy has been estimated to 
affect around 600 000 people in the UK. In addition, there will be an 
estimated further 5–30% of individuals who have been incorrectly 
diagnosed with epilepsy. The incidence of epilepsy in high-income 
countries is estimated to be 50 per 100 000 per year. The prevalence 
of active epilepsy in the UK is estimated to be 5–10 cases per 1000 
(Sander & Shorvon, 1996). 
Two-thirds of people with epilepsy can have their seizures com-
pletely controlled with anti-epileptic drugs (AEDs). Such management 
improves health outcomes and can also help to minimise detrimental 
impacts on social activities, education and employment. However, a 
third of people with epilepsy do not achieve complete seizure control 
despite trying multiple medications. Coexistence of epilepsy and 
ID in an individual poses unique challenges. Appropriate diagnosis 
(history, investigation, classifications and aetiology) and management 
of epilepsy are essential to reduce the considerable social impact, 
potential stigmatisation, secondary handicap and low self-esteem 
compounded by social exclusion as experienced by people with ID. 
Intellectual disability and 
epilepsy
Both epilepsy and ID may be caused by a range of pathological 
processes (Forsgren et al, 1990; Bowley & Kerr, 2000; Lhatoo & 
Sander, 2001). Among people known to ID services in the UK, the 
prevalence of epilepsy is about 20–30%, and this figure may be 
higher in the residual populations of long-stay institutions (Bell & 
Sander, 2001). The prevalence of epilepsy in ID is between 22% and 
26%, and increases with increasing severity of ID (McGrother et al, 
2006; Robertson et al, 2015a). The estimated prevalence for mild ID 
is around 10%, compared with 30% for those with moderate, severe 
or profound ID (Robertson et al, 2015b). Two-thirds of people with 
ID and epilepsy are considered to show a poor response to anti-ep-
ileptic medication (McGrother et al, 2006), and people with ID and 
epilepsy often have more physical impairments than those with ID but 
not epilepsy (Robertson et al, 2015a). However, although psychiatric 
and behavioural comorbidities are common in people with ID, rates 
are not necessarily higher than in those with ID without epilepsy 
(Robertson et al, 2015a). Concomitant epilepsy in people with ID 
is associated with high healthcare costs and increased mortality 
(Robertson et al, 2015a). In the UK, convulsions and epilepsy were 
found to be the most frequent cause of what were considered as 
potentially avoidable hospital admissions in people with ID, accounting 
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for approximately 6000 admissions per year, equivalent to 40% of all 
emergency admissions for ambulatory care sensitive conditions in 
adults with ID (Glover & Evison, 2013). This is representative of the 
problem worldwide (Balogh et al, 2010). 
The coexistence of ID, drug-refractory epilepsy and neurological 
deficits is often associated with genetic/chromosomal abnormalities 
or structural brain pathology (either damage or maldevelopment of 
the brain) (Busch et al, 2014). The number of known single-gene 
mutations associated with ID and epilepsy is increasing; some of 
these are important for treatment strategies and so should always 
be considered. For example, SCN1A mutations are associated with 
Dravet syndrome, which is characterised by febrile and non-febrile 
seizures beginning in the first 12 months of life, episodes of status 
epilepticus, and initial normal development but intellectual decline in 
the second year of life. This syndrome can respond poorly to drugs 
that block sodium channels (e.g. lamotrigine, carbamazepine and 
phenytoin) (Catterall, 2012). On the other hand, tuberous sclerosis 
may respond well to vigabatrin; however, the serious specific side- 
effects of treatment with this drug need to be considered (Curatolo 
et al, 2001). GLUT1 deficiency, which is associated with seizures in 
the first 4 months of life, dystonia (in particular, exercise-induced 
dyskinesia) and ID, may respond particularly well to a ketogenic diet 
(Klepper et al, 2005).
Supporting people with ID and epilepsy, especially those with poorly 
controlled epilepsy, requires high levels of competence and confi-
dence in staff in community settings (Kerr et al, 2014; Thompson et 
al, 2014).Seizures in people with ID are commonly of multiple types 
and are often resistant to single-drug treatment (Branford et al, 1998; 
Amiet et al, 2008; Matthews et al, 2008). This is especially true in 
severe and profound ID. Uncontrolled epilepsy can have serious 
negative consequences that affect both quality of life and mortality 
(Kerr & Bowley, 2001a,b). There are guidelines (Working Group of 
the International Association of the Scientific Study of Intellectual 
Disability 2001; Kerr et al, 2009) on the management of epilepsy in 
people with intellectual disability that cite the relevant evidence base; 
where this evidence base was found to be lacking, an international 
consensus group of epileptologists have come up with a consensus 
statement (Kerr et al, 2011). 
The management of epilepsy is also particularly important because 
of the risk of sudden unexpected death in epilepsy (SUDEP). The 
incidence of sudden death appears to be 20 times higher in patients 
with epilepsy compared with the general population, and SUDEP is the 
most important directly epilepsy-related cause of death (Hesdorffer 
et al, 2011; Doran et al, 2016). People with drug-resistant epilepsy 
are at particular risk of SUDEP (Hesdorffer et al, 2011; Shankar et al, 
2013; Doran et al, 2016). NICE (2012) in England and Wales, and the 
Scottish Intercollegiate Guidelines Network (SIGN, 2015) in Scotland, 
both recommend that patients, carers and families need to be coun-
selled using information tailored to the patient’s relative risk of SUDEP. 
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An evidence-based risk factor checklist to engage patients (including 
people with ID) in such a person-centred discussion has been devel-
oped (Shankar et al, 2013). There is evidence that a bespoke service, 
which takes into account current good practice for supporting people 
with ID and amalgamates it with good practice for managing epilepsy, 
can reduce deaths in ID (Shankar et al, 2014, 2016). This is further 
highlighted by a recent ILAE report (Kerr et al, 2016). 
Mental illness and behavioural 
symptoms
Making a diagnosis of epilepsy in people with ID may be confounded 
by the high prevalence of psychiatric disorders. The point prevalence 
of mental illness in this population is over 50%, with many individuals 
having more than one diagnosable psychiatric illness (Cooper et al, 
2007). Furthermore, the ID population with active epilepsy are at 
greater risk of developing mental illness (Turky et al, 2011). This can 
have an impact on both the assessment and the treatment of epilepsy. 
There may be some confusion for clinicians about behaviours that are 
associated with epilepsy and its treatment, and those that are not. 
There needs to be consideration of the role of psychotropic medication 
that has epileptogenic potential (Kerr et al, 2011). Specific guidance 
on considering behavioural manifestations and neuropsychiatric man-
agement is available for this population (Kerr et al, 2011, 2016). 
The semiology of a generalised tonic–clonic seizure does not mimic 
many other conditions, and the nature of these episodes is usually 
well defined. By contrast, the diagnosis of focal seizures is reliant 
upon a description from the individual and a witness. This may be 
further complicated by the presence of associated ictal or post-ictal 
automatisms. Differentiating these more complex seizure presenta-
tions from psychiatric disturbance or non-epileptic seizures can be 
very challenging, even in the general population. These presentations 
in the ID population are further complicated by the high prevalence 
of repetitive stereotyped motor behaviours (Paul, 1997), and a large 
proportion of patients referred to specialist epilepsy units have a misdi-
agnosis of epilepsy. Observable abnormal movements thought to be of 
an epileptic nature have frequently been found by neurophysiological 
testing to be non-seizure-related (Donat & Wright, 1990). 
When considering a differential diagnosis, obtaining a detailed under-
standing of the observed behaviour and the context provides essential 
information. This may be aided by the use of relevant investigations, 
including video electroencephalography (video-EEG). More complex 
scenarios may require detailed functional analysis from other profes-
sionals within the multidisciplinary team.
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Current views and expectations 
of professionals
The British branch of the ILAE working group on services for people 
with ID and epilepsy recently surveyed the membership of key stake-
holders involved in the delivery of care to this population (2016–2017) 
(M. Kerr, personal communication, 2017). The clinicians surveyed 
included a range of health professionals affiliated to the ILAE, the 
Faculty of Psychiatry of Intellectual Disability of the Royal College of 
Psychiatrists, the Association of British Neurologists, and the Epilepsy 
Nurses Association. The work setting of responders ranged from com-
munity ID teams to tertiary epilepsy centres. The level of experience 
and specialist knowledge in the clinical work varied significantly. The 
percentage of these professionals’ workload spent treating epilepsy 
ranged from 9.3 to 29.6%. The percentage of case-load involving a 
person with a diagnosis of ID showed two distinct peaks: those with 
limited contact and those working only with the ID population. The 
survey focused on a number of key domains exploring diagnosis 
and medical treatment, delivery of service, risk assessment, and the 
broader impact on quality of life. 
The time taken for individuals with ID and new-onset epilepsy to 
undergo routine investigation for epilepsy, such as EEG and magnetic 
resonance imaging (MRI), was commonly reported to be at least 1–3 
months, far beyond recommendations made by NICE (2012). Similar 
waiting times were reported for investigations in the ongoing man-
agement of epilepsy. Individuals with ID often have other significant 
comorbidities alongside their cognitive deficits, including, for example, 
communication impairment. As a result, prolonged investigations 
may be intolerable without other interventions. It is often necessary 
for investigations such as MRI to be conducted under general anaes-
thetic. For individuals who lack capacity to make decisions about 
their health, such investigation must only be considered following a 
best interests meeting in accordance with the Mental Capacity Act 
2005 (in England and Wales). Survey results demonstrate that this 
significantly increases the waiting time for necessary investigations, 
with the majority of patients waiting at least 1–3 months, some more 
than 6 months. The fact that a large proportion of clinicians treating 
this population group are unable to directly request such investigations 
(as they now fall within the ambit of neurology or similar mainstream 
services) is also likely to be a contributing factor. It appears that health 
services are not routinely putting reasonable adjustments in place to 
meet the needs of this population.
People with ID and epilepsy are more likely to present with treat-
ment-resistant epilepsy. The results highlight that there are still a 
minority of clinicians who would not consider non-pharmacological 
interventions that have proven benefit for treatment-resistant epi-
lepsy – including epilepsy surgery, vagus nerve stimulation (VNS) 
and ketogenic diet.
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Almost universally, responders to the ILAE survey were actively involved 
in the assessment and management of key risk areas, including risk 
of drowning, admission to hospital and medication side-effects, as 
recommended by NICE (2012). Nearly 90% of respondents reported 
that they assess and discuss SUDEP, a significant improvement on 
previous assessments of clinical practice. There is still a need to 
disseminate information about the importance of assessing the 
need for nocturnal monitoring systems. Encouragingly, the majority 
of responders were actively involved in supporting people with ID and 
epilepsy and their carers in decisions around access to education, 
employment, and other social issues.
Following the results of this survey, the British branch of the ILAE 
working group for people with ID and epilepsy recommends that the 
ILAE (British chapter) works to promote collaboration between the 
key stakeholder governing bodies involved in the delivery of care to 
this population. The development of care pathways will help to ensure 
that the needs of people with ID are met and that reasonable adjust-
ments are made. Such collaboration between professionals would 
also allow for the sharing of expertise to ensure person-centred care. 
A specific focus needs to be on the complex needs commonly found 
in this population, including psychiatric illness, neurodevelopmental 
comorbidity and physical health issues. Recognition of the complex-
ity and diversity of treatment, management, emergency care, legal 
issues and quality of life is imperative. Delivery of care for a person 
with multimorbidity may require input from different professionals, 
depending upon their expertise; however, there needs to be a central 
responsible team or specialist to help coordinate the various aspects 
of care and provide governance and clinical assurance. 
Specific areas of concern
Kerr et al (2014) introduced a White Paper which built on the publica-
tion of the ILAE and International Bureau for Epilepsy report Listening 
for a Change: Medical and Social Needs of People with Epilepsy and 
Intellectual Disability (Kerr et al, 2013). This section has been devel-
oped using the White Paper as a benchmark for current concerns 
and practice. 
 Actions in four domains are indicated.
1 The development of standards and initiatives that would enhance 
diagnosis, pathways to investigation and treatment.
2 The development of guidelines for treatment, specifically best 
practice in the management of AEDs, including rescue medication.
3 The development of standards for primary care, multidiscipli-
nary teamwork and clinical consultations, with an emphasis on 
the need to enhance communication and improve access to 
information.
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4 The enhancement of links among different stakeholders, including 
medical services, educational establishments, employment 
services, organisations providing opportunities for social engage-
ment, and family members (Kerr et al, 2014).
The authors also outlined four major areas of concern, of which two 
are directly relevant to this report. Specific areas of concern relevant 
to the scope of this report are summarised below. 
Diagnosis and medical treatment
 z Key concerns exist around misdiagnosis given the complexity 
of comorbid presentation.
 z There are particular concerns around poor communication during 
consultation.
 z Challenges exist for accessing appropriate investigations.
 z Medication issues, including side-effects and difficulties in ensur-
ing treatment monitoring, are particular worries.
 z There is a need for greater knowledge transfer to all stakeholders.
 z There is a requirement for more accessible information sources.
Service delivery
 z There are major concerns regarding engagement of multi 
disciplinary team approaches.
 z Manner and quality of consultations are cause for concern; in 
particular, they are brief and possibly ineffective.
 z There is a lack of listening and involvement of key stakeholders, 
including family.
 z There is a lack of expertise in primary care settings.
 z Use of epilepsy nurse specialists in training carers is unsatisfactory. 
 z Standards of care delivery and service provision vary in different 
regions of the UK. 
Special educational and family life 
 z Specific concerns exist around the lack of a holistic model to 
support access across various social domains. 
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Box 1 Recommended actions
Investigations and diagnosis in individuals with complex needs
 z Establish a working group to develop standards for the diagnosis of epilepsy in people with an intellectual 
disability (ID), both for adults and children; this should include measures to investigate aetiology, 
misdiagnosis and equitable access to treatment.
 z Develop educational initiatives to improve clinician communication when an individual has impaired 
communication, and support the call for extended consultations to ensure sufficient time is afforded to 
patients with an ID.
 z Establish a working group to identify a pathway to investigation for those with complex needs, to include a 
discussion of best interests and the use of anaesthesia or sedation.
Medication (including rescue medication)
 z Establish a task force to develop guidelines for the treatment of epilepsy in people with an ID.
 z Produce a position statement establishing best practice for the identification and management of anti-
epileptic drug (AED) side-effects in people with an ID. Specific attention is needed to address drug 
interactions owing to the increase in prescribing for comorbid conditions.
 z Develop audit templates to ensure that all people with an ID who have epilepsy have had an assessment 
regarding rescue medication, that such medications are prescribed when appropriate, and that staff and 
family members have had adequate training in their administration.
Enhancing medical services 
 z Develop guidance on standards of information exchange in clinic settings; these should identify the input 
from patients, caregivers, families and professionals.
 z Develop guidance on the role of primary care services in the management of comorbid ID and epilepsy, 
and their interaction with specialist services.
 z Ensure accessible information on all aspects of epilepsy management is made available within services.
 z Explore mechanisms for improving communication in clinical situations, including shared decisions 
methodology and option grids.
 z Promote the development of epilepsy specialist nurse provision, with a particular focus on those 
supporting people with an ID either in specialist epilepsy services or in services providing healthcare to 
people with an ID.
 z Develop guidance, including minimum standards, on multidisciplinary team working for individuals with 
epilepsy and ID.
 z Develop guidance on appropriate duration of consultations with people with complex 
communication needs.
 z Develop training manuals to support non-specialist services managing epilepsy in community settings.
Adapted from Kerr et al (2014).
Proposed framework
Kerr et al (2014) also outlined a proposed framework to enhance the 
delivery of support for people with ID who have epilepsy. Some of 
the specific recommendations from the paper have been reproduced 
in Box 1. 
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The key issues relevant to this strategy document were:
1 keeping people with ID who have epilepsy at the core of change, 
especially given that inclusion of this group tends to be ham-
pered by the complexity of their treatment, which inadvertently 
contributes to their invisibility within mainstream epilepsy services 
2 recognising that the evidence base for the effectiveness of inter-
ventions in mainstream care for this vulnerable population is weak 
3 recognising that there is a clear need for the development of 
an appropriate clinical infrastructure to support the delivery of 
person-centred holistic care, taking into consideration both the 
ID and the epilepsy. The infrastructure will require consensus on 
standards and guidelines spanning a range of areas, including 
diagnosis and treatment across multiple stakeholders in primary, 
secondary and tertiary care. In secondary care, this would require 
contribution from specialists in ID and neurology, and nursing 
specialists in epilepsy. 
The College’s Faculty of Psychiatry of Intellectual Disability has taken 
this framework seriously, and this strategy document is an attempt 
to provide a view of a potential holistic approach. A critical analysis 
of its relevance is provided in Box 2.
Box 2 Strengths, weaknesses, opportunities and threats for the proposed model
Strengths
 z Simple and uncomplicated
 z Addresses a major health concern
 z Provides clarity of roles and 
expectations
 z A coherent and measured response 
to concerns on the treatment and 
management of people with ID and 
epilepsy
 z Supported by Faculty and its members 
 z Developed using a robust evidence 
base and tested using focus groups
 z No major changes proposed: cost 
neutral
Weaknesses
 z Untested in any large geographical area
 z Tries to harmonise diverse working 
practices across various regions and 
countries, thus risking losing specifics 
in focus
 z Looks primarily at the role of the ID 
psychiatrist and not the larger system
Opportunities 
 z May serve as a template for other 
stakeholder organisations to develop 
their strategies
 z Improve care to people with ID and 
epilepsy
 z Improve training and service delivery
 z Could be adopted in other countries 
Threats
 z Lack of integrated response from other 
stakeholders
 z Inadequate resources locally





Our working group agreed key objectives and developed the current 
strategy document setting out how these would be addressed.
Objectives
 z Identify the general and specific needs and requirements of 
people with ID who have epilepsy, with particular focus on the 
impact of ID on epilepsy.
 z Develop and deliver a matrix to evaluate current epilepsy care 
from an organisational and individual clinician perspective. 
 z Develop a competency-based framework for psychiatrists work-
ing with people with ID to be self-aware regarding their skills and 
their level of training, by using the matrix to highlight personal and 
organisational responsibility in delivering epilepsy care. 
 z Consider and suggest pathways for inclusion of epilepsy com-
petencies in the ‘Gold Guide’ for postgraduate specialty training 
in the UK. 
 z Provide a template to open a dialogue at a national level with other 
key health professional stakeholders, including epilepsy specialist 
nurses, neurologists and GPs to provide a unified strategy for 
diagnosis and management of epilepsy in people with ID to help 
improve outcomes.
 z Offer suggestions for continuing professional development (CPD) 
to psychiatrists working with people with ID to provide them-
selves, their patients and their employers with assurance of their 
skills and competences in epilepsy care delivery.
Strategy document development 
16 June 2016
A working committee was formed from the larger Faculty executive 
committee. The committee included psychiatrists whose primary job 
role is in ID but who had a range of expertise in epilepsy. Advisors to 
support the core committee were identified. The preliminary meeting 
set the proposed objectives and proposed framework. The executive 
committee unanimously agreed with the working committee proposal 
College Report CR20318
that epilepsy needs to be ‘core business for the Faculty’ and that steps 
needed to be taken to enshrine epilepsy care in routine practice for 
all psychiatrists working in ID. Over the next 3 months, the working 
group collaborated via email and telephone. Best practice documents, 
including those from NICE and SIGN, and recent white papers about 
epilepsy and ID and current models of care (see the Appendix) were 
selected, reviewed and analysed. 
30 September 2016
The findings were collated and presented to a focus group in the 
Annual ID Residential Conference 2016 as part of a break-out session. 
The focus group was well attended by a diverse group of practition-
ers. Clinical vignettes were used to gain insight to participants’ skills, 
aims and wishes. Feedback was collected and assimilated into the 
developing document and plan. 
23 January 2017 
An update on the planned structure of the document was presented 
at the Faculty of Psychiatry of Intellectual Disability executive meeting. 
Approval was gained to continue in the direction identified and specific 
issues were highlighted.
26 January 2017 
A strategy meeting brought together the working committee to iden-
tify and populate the core structure of the strategy document. Good 
practice tools were identified, discussed and considered as to their 
suitability for inclusion. The structure of the strategy document was 
finalised and agreed. 
15 February 2017
All working committee members had contributed their pieces of work 
to the relevant sections of the document by this date. 
25 February 2017 
The first preliminary draft was developed and sent to the three mem-
bers and advisors of the strategy who have a significant role in epilepsy 
and ID care.
15 March 2017
The report was circulated to all working committee members for 
comments and feedback.
20 March 2017





The recent ILAE survey highlighted expectations and current gaps in 
everyday practice. However, it is important to provide benchmarks 
for what should be considered good practice and safe care delivery 
for people with ID when accessing services for management of their 
epilepsy. This requires the amalgamation of current good practice 
guidance in both the epilepsy and ID sectors. 
NICE guidance
The NICE (2012) guideline Epilepsies: Diagnosis and Management 
(CG137) was originally written in 2004 and updated in 2012 to incor-
porate the results of the 2007 SANAD trial (Marson et al, 2007). In 
February 2013, NICE produced two accompanying sets of quality 
standards for epilepsy in adults and in children and young people 
(NICE, 2013a,b). The quality standards each consist of nine outcome 
indicators which allow for audit of services. These guidelines relate 
to care delivery in the NHS in England and Wales.
The NICE guidelines are relevant to people with ID who have epilepsy, 
with this population having a specific section. The guidance starts 
with a focus on person-centred care and then outlines key priorities 
for implementation in the areas of diagnosis, management, prolonged 
or repeated seizures, special considerations for women and girls of 
childbearing potential, and review/referral. 
The guidance then outlines more details with respect to information 
sharing (including information about SUDEP), diagnosis, investigations, 
classification, management and review. There is a large section (pp. 
23–39) on pharmacological treatment of the different seizure types 
and syndromes. There is a section on the need for referral to a tertiary 
specialist centre for complex or refractory epilepsy, including where 
there is psychological or psychiatric comorbidity. Finally, there are 
specific sections for women, people with ID, young people, older 
people and those from Black and minority ethnic groups.
A ‘specialist’ is defined as a medical practitioner with training and 
expertise in epilepsy. A ‘tertiary epilepsy specialist’ is an epileptol-
ogist who devotes the majority of their time to epilepsy, working in 
a multidisciplinary tertiary referral centre, and is subject to regular 
peer review.
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The nine quality statements (NICE, 2013a) are as follows.
1. Adults presenting with a suspected seizure are seen by a spe-
cialist in the diagnosis and management of the epilepsies within 
2 weeks of presentation.
2. Adults having initial investigations for epilepsy undergo the tests 
within 4 weeks of these being requested.
3. Adults who meet the criteria for neuroimaging for epilepsy have 
an MRI scan.
4. Adults with epilepsy have an agreed and comprehensive written 
care plan.
5. Adults with epilepsy are seen by an epilepsy specialist nurse who 
they can contact between scheduled reviews.
6. Adults with a history of prolonged or repeated seizures have an 
agreed written emergency care plan.
7. Adults who meet the criteria for referral to a tertiary care specialist 
are seen within 4 weeks of referral.
8. Adults with epilepsy who have medical or lifestyle issues that 
need review are referred to specialist epilepsy services.
9. Young people with epilepsy have an agreed transition period 
during which their continuing epilepsy care is reviewed jointly by 
paediatric and adult services.
SIGN guidance 
SIGN, as part of Healthcare Improvement Scotland, has the task of 
developing and disseminating clinical practice guidelines based on 
current best evidence for the Scottish population.
The SIGN (2015) guideline Diagnosis and Management of Epilepsy in 
Adults (SIGN143) updated and expanded the previous 2003 guide-
line (SIGN70) to address issues that had arisen from developments 
in service delivery, diagnostic processes and therapeutic interven-
tions, including new pharmacological agents. Like all SIGN guidelines, 
SIGN143 was created using a standardised methodology: establishing 
a multidisciplinary, nationally representative group, which conducts a 
systematic review of relevant literature and evidence and, after critically 
appraising the evidence, makes recommendations according to the 
supporting evidence.
As the title suggests, SIGN143 is concerned with the diagnosis and 
management of epilepsy in adults only. There is currently no SIGN 
guideline for epilepsy in children. SIGN143, similar to NICE CG137, 
dedicates a specific section to the management of people with ID 
and epilepsy, particularly emphasising equality of access with regard 
to assessment and treatment.
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SIGN143 key recommendations relate to: 
 z diagnosis, which should be made by a specialist, with a clear 
history from the patient and an eyewitness as the mainstay
 z treatment, including initiation of AED treatment after a first tonic–
clonic seizure 
 z maintenance treatment 
 z EEG assessment and monitoring 
 z medication choices to treat prolonged seizures, including status 
epilepticus. 
Key recommendations are also made in relation to specific pop-
ulations, including women and people presenting with psychiatric 
comorbidity. Finally, mortality and SUDEP are highlighted, as well as 
models of care emphasising the importance of a structured manage-
ment system and active chronic disease management.
Although there are clear overlaps between SIGN143 and NICE CG137 
– as both are based on the same evidence – there are some differ-
ences. These include the definition of ‘specialist’. SIGN143 is more 
prescriptive in its definition of a specialist and the assessment process. 
It recommends: ‘The diagnosis of epilepsy should be made by an 
epilepsy specialist [...] An epilepsy specialist has been defined as a 
trained doctor with expertise in epilepsy as demonstrated by training 
and continuing education in epilepsy, peer review of practice and 
regular audit of diagnosis. Epilepsy must be a significant part of their 
clinical workload (equivalent to at least one session a week).’ SIGN 
also recommend that: ‘The diagnosis of epilepsy is most appropri-
ately delivered in the setting of a dedicated first-seizure or epilepsy 
clinic.’ There are few, if any, psychiatrists working in ID in Scotland 
who satisfy this particular recommendation. Additionally, SIGN does 
not offer a system of quality standards. However, the principles set 
out in the NICE outcome measures are appropriate and could be 
applied in keeping with the SIGN recommendations. 
Intellectual disability
The NICE and SIGN guidelines state that a person with ID should 
have the same access to treatment for epilepsy as anybody else, 
and that if there are additional treatment needs, the most appropriate 
health professionals should meet those needs. Meeting these needs 
is easier said than done.
Epilepsy Action (www.epilepsy.org.uk), in their work on good prac-
tice, aim to promote equality of access to quality care for all people 
with epilepsy. They have recognised that epilepsy is more difficult to 
diagnose in people with ID because of diagnostic overshadowing 
created by communication deficits, repeated behaviours and move-
ment disorders which can be mistaken for epilepsy. For an epilepsy 
specialist to decide which symptoms are epilepsy and which are not 
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can be difficult without expertise in ID. Furthermore, people with ID 
may have additional needs, such as feeding and swallowing problems, 
constipation, repeated infections (with associated treatment) and pain. 
The Mencap (2012) document Treat me Right! reiterated the need for 
healthcare professionals to have appropriate training in ID to reduce 
the potential for incorrectly ascribing physical health needs to the ID. 
Some of the associated concerns are highlighted by the Confidential 
Inquiry into Premature Deaths of People with Learning Disabilities 
(CIPOLD) (Heslop et al, 2013). This inquiry identified four long-term 
conditions that were significantly more prevalent among people with 
ID who had died: epilepsy, hypothyroidism, cerebral palsy and type 2 
diabetes. Of these long-term conditions, epilepsy was the most likely 
to be the cause of death. CIPOLD reported that 43% of the study 
cohort of people with IDs had been diagnosed with epilepsy, and 
72% of these had experienced seizures in the past 5 years. There 
were a number of people with a diagnosis of epilepsy who remained 
in treatment, although they had not had any known seizures in the 
past 5 years. 
Weak spots were found in the epilepsy care pathway, despite the 
majority of individuals being identified, whether by themselves, family 
or paid carers, as being unwell. Of those identified by health services 
as being unwell, problems with investigations, referral to a specialist 
and misdiagnosis were among the top five barriers to access to stand-
ard care. CIPOLD recognised the need for a clear care pathway so 
that people receive optimal, evidence-based care for their conditions, 
and to ensure that people with ID and epilepsy have access to the 
same investigations and treatments as anyone else. It acknowledged 
that services may need to be delivered differently in different areas, 
based on demographics and local established services, to achieve 
the same outcome.
Good practice guidance for ID 
There have been numerous national developments in the past decade 
focused on improving health and social outcomes for people with 
ID. The majority of the health-related focus has been on mental and 
general physical health. While not directly focused on epilepsy, many 
of these documents provide a good framework which can be adopted 
to support the delivery of high-quality epilepsy care for people with ID. 
Most, if not all, psychiatrists working in the field of ID would be familiar 
with the documents that follow. This subsection is intended to help 
psychiatrists and policy makers to consider the wealth of evidence 
that has been established to help plan corresponding outputs and 
structures for people with ID and epilepsy. 
The Green Light for Mental Health (National Development Team for 
Inclusion, 2013) is a toolkit developed to support mental health ser-
vices in delivering the objectives of the National Service Framework for 
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mental health in people with ID in England. Using the checklist allows a 
provider to establish what is in place and working well for people with 
ID and mental health issues, as a first step towards improvement and 
development of local services. Using the self-assessment checklist at 
regular intervals allows the provider to track developments, celebrate 
achievements and move towards developing better services for people 
with ID, benchmarked against national guidance and expectation. 
Although it is not in use in other countries of the UK, it outlines a good 
model of care which can be adapted to develop a similar approach 
for epilepsy. This toolkit can be modified to help assess, monitor 
and develop quality epilepsy services for people with ID. A model is 
provided in the Appendix document.
Improving access to care
Across the UK there have been many policies regarding how gov-
ernment services, including health and social care, are provided for 
people with ID to promote inclusion, choice and rights. These strate-
gies, such as Valuing People Now (Department of Health, 2009) have 
allowed significant gains to be made, including the decommissioning 
of old long-stay hospitals, promotion of person-centred plans and 
the introduction of primary care-led annual health checks and health 
action plans. However, it was noted that after many years significant 
inequalities still existed in access to healthcare, and thus there was an 
attempt to emphasise the need for partnership working and recogni-
tion that people with ID will need support for the whole of their lives. 
The Improving Health and Lives (IHAL, 2012) Learning Disabilities 
Observatory for England recognises that people with ID die younger 
than the general population and that they face avoidable significant 
health inequalities. The Equality Act 2010 places responsibilities on 
providers to make reasonable adjustments so as to improve access to 
care (Office for Disability Issues, 2011). Services should go beyond just 
providing quality care and ensure that their design allows good access 
for people with ID. IHAL recognises that good epilepsy services are 
likely to reduce the risk of seizures and the number of unplanned 
hospital admissions, and will thus save money. Reasonable adjust-
ments include home visits where there is a reasonable chance of the 
patient getting distressed in a busy hospital environment, extended 
clinic appointments and pre-visits to see scanners.
There is other good practice in psychiatric care for people with ID 
which can be adopted or developed for the delivery of epilepsy care 
for these patients. Stopping Over-Medication of People with Learning 
Disabilities (NHS England, 2016) is a collaborative attempt, endorsed 
by the Royal College of Psychiatrists and others, to increase vigilance 
regarding excessive medication in those with mental health problems 
and challenging behaviour. Care of patients with comorbid physical 
health problems, including epilepsy, would require similar vigilance 
and management, in context and not in isolation. This specialist skill 
most likely sits within an ID psychiatrist’s role. 
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It is important that the views of individuals with ID are considered when 
deciding what pathway best meets their needs, or when considering 
medication. The Mental Capacity Act 2005 requires an assessment 
of capacity in making such decisions. Where this is lacking, there is a 
requirement for the best interests of the individual to be considered, 
in collaboration with carers and families.
The Autism Act 2009 provides a legal requirement for the health 
and social care needs of autistic people to be met. The ID epilepsy 
strategy that we present in this document recognises the need for 





The current evidence suggests that the delivery of epilepsy care and 
access to epilepsy pathways for people with ID are fragmented and 
subject to geographical variations. It is imperative that the patient 
be at the centre of any services designed. Delivery of epilepsy care, 
given its complexity, needs to be ‘everyone’s business’ (as opposed 
to ‘someone’s business’) among all stakeholders. For the purpose of 
the Faculty to support psychiatrists working with people with ID, we 
propose a competency framework of Bronze/Silver/Gold to identify 
their skill set and the minimum expectations they need to have of 
their local service to provide their competency level of epilepsy care. 
The advantages and challenges of this model were summarised in 
Box 2 (p. 16). 
We suggest that all psychiatrists working with people with ID have a 
minimum Bronze level skill set to provide assurance of basic safety. It 
is hoped that the template will serve as a pathway for those currently 
a Bronze to move themselves to Silver and Gold if they wish to do so. 
Each category has been developed to be benchmarked against the 
relevant NICE outcome indicators, and is also in line with SIGN143 
recommendations. The linked NICE outcome standards for each 
category are provided in Box 3 (p. 27).
Bronze 
All psychiatrists working with people with ID should have a ‘Bronze’ 
level of skills. We recognise that these psychiatrists may or may not 
provide direct care for epilepsy, so the NICE quality standards may 
not all apply. However, they should still be familiar with the content 
of the guidelines and quality standards, or alternatively follow SIGN 
recommendations if appropriate. At Bronze level, the psychiatrist 
should have the following competencies.
 z Be able to diagnose, assess and manage medication of epi-
lepsy to a reasonable standard. This includes knowledge of the 
diagnostic process of epilepsy and non-epileptic attack disor-
der (NEAD); an understanding of investigations relevant to the 
condition; psychiatric side-effects of AEDs; and the psychiatric 
manifestations of epilepsy, including an appreciation of the asso-
ciations between challenging behaviour, epilepsy and ID. 
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 z Understand the precipitating, perpetuating, predisposing and 
protective factors for epilepsy in a person with ID. 
 z Know the risks associated with epilepsy and be able to complete 
and scrutinise risk assessments to ensure that their service deliv-
ers on mitigating SUDEP, as well as social and environmental 
risks. 
 z Understand epilepsy and its impact on psychiatric illness and 
behaviour. 
 z Be aware of AEDs and their interactions with other drugs (psy-
chiatric drugs in particular). 
 z Ensure that risks are identified and appropriately mitigated, includ-
ing, for example, that a rescue medication protocol is in place 
if necessary. 
 z Be familiar with local or regional pathway for epilepsy, either in 
general or specific to ID, including relevant clinicians in neurology 
or other epilepsy services, and the local area epileptologist.
 z Be able to lead on a management level (although there will be 
overlap with other clinical staff, particularly nursing) to provide 
holistic and safe care.
 z Be familiar with the best interests process for treatment of those 
who lack capacity, and the use of restrictive interventions as part 
of epilepsy management (helmets, braces, holds) to prevent 
self-injury.
 z Lead on multidisciplinary team care planning, with epilepsy being 
part of a wider health plan with input into annual health checks, 
hospital passport etc.
Silver 
At Silver level, psychiatrists will be much more familiar with the specific 
content of the NICE and SIGN guidelines, as they will be managing 
epilepsy directly with the back-up of a neurology service or other 
specialist epilepsy service with which they have close links, as well 
as having access to services such as an epilepsy liaison nurse and 
appropriate investigations. At this level, the psychiatrist should be able 
to deliver all Bronze level requirements, in addition to the following.
 z Be able to diagnose new epilepsy.
 z Initiate, withdraw and titrate medication.
 z Diagnose, address and treat any associated mental illness or 
challenging behaviour occurring alongside the epilepsy, by man-
aging both the AEDs and psychiatric treatments.
 z Manage SUDEP discussions with patients and carers, as well 
as risk mitigation.
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Gold
At Gold level, psychiatrists are likely to work very closely with, if not 
alongside, tertiary care specialists. They will have a level of knowl-
edge and skills about epilepsy which goes beyond the NICE or SIGN 
guidelines and will be able to manage all aspects of epilepsy diagno-
sis and management. All NICE quality standards will be applicable, 
and these psychiatrists and their services are likely to be involved in 
education and standard setting for people with ID and epilepsy at a 
national level. At Gold level, the psychiatrist will practise all Bronze 
and Silver requirements, as well as the following.
 z Identify and manage specialist conditions, including epileptic 
encephalopathy. 
 z Dedicate a significant part of their clinical work and CPD activity 
to epilepsy care.
 z Support referral for epilepsy surgery assessment, including being 
able to refer patients for VNS or other specific epilepsy surgery.
 z Review complex epilepsy in patients with autism and/or specific 
genetic conditions.
Box 3 NICE outcome indicators associated with proposed models
Bronze
 z That adults with epilepsy have an agreed and comprehensive 
written care plan
 z That adults with a history of prolonged or repeated seizures have 
an agreed written emergency care plan
 z That adults with epilepsy who have medical or lifestyle issues that 
need review are referred to specialist epilepsy services
 z That young people with epilepsy have an agreed transition period 
during which their continuing epilepsy care is reviewed jointly by 
paediatric and adult services
Silver
 z That adults presenting with a suspected seizure are seen by a 
specialist in the diagnosis and management of the epilepsies within 
2 weeks of presentation
 z That adults having initial investigations for epilepsy undergo the 
tests within 4 weeks of these being requested
 z That adults who meet the criteria for neuroimaging for epilepsy 
have an MRI scan
 z That adults with epilepsy are seen by an epilepsy specialist nurse 
who they can contact between scheduled reviews
The above are in addition to all Bronze level indicators
Gold
 z That adults who meet the criteria for referral to a tertiary care 
specialist are seen within 4 weeks of referral








This strategy recognises that there may be ID psychiatrists who do 
not want to develop a Silver or Gold set of competencies in epilepsy, 
choosing instead to subspecialise in other areas based on their inter-
est, the services in which they are working, and the available training. 
The expectation is that an ID psychiatrist will have a basic Bronze level 
of competency in ID to sit alongside the other core skills expected 
of them (Fig. 1).
There will be considerable overlap in the skills outlined in the different 
categories. A summary of how this could work in practice is provided 
in Fig. 2.
Fig. 1 Schematic showing how epilepsy would sit with other subspecialties.
Patient with ID and epilepsy, seen 
in psychiatric context
Bronze
• Identify and manage 
epilepsy needs
• Assess impact 
of disease and 
treatment on mental 
disorder
• Able to treat NEAD















































Fig. 2 The psychiatrist’s role in epilepsy service delivery. AED, anti-epileptic drugs; EEG, electroencephalogram; ID, 
intellectual disability; MRI, magnetic resonance imaging; NEAD, non-epileptic attack disorder; SUDEP, sudden unexpected 
death in epilepsy; VNS, vagus nerve surgery. Figure adapted with permission from Epilepsy in People with ID: Can we Reduce 
the Burden of Disease? Keynote presentation by Professor Mike Kerr at the Faculty of Psychiatry of Intellectual Disability 
Annual Conference, 26–27 September 2013.
Psychiatrist has no 






Although the scope of this document is primarily to identify roles, 
competencies and training issues for psychiatrists working with people 
with ID, this cannot be done without providing a brief overview of 
what the expectations should be of the larger care model to ensure 
a suitable working environment. The strategy aims to promote the 
idea that clinicians work in competent teams. Epilepsy care is a 
multidisciplinary field, and there is a need to have suitable access to 
a competent team. The psychiatrist should not work in isolation, as 
much of the risk assessment work and epilepsy training is done by 
nursing colleagues. There is also a role for allied health professionals, 
depending on the complexity and multimorbidity. Many psychiatrists 
might not see themselves as specialists on the Gold or even Silver 
level, but might consider that their teams were specialist enough on 
the basis of their shared skills and knowledge. 
Here, we provide a summary of service delivery and a proposed audit 
tool. This constitutes a set of wishes more than recommendations. 
The hope is that providers of epilepsy care or psychiatrists interested 
in developing local services will use this list to assess and develop 
facilities. Those in bold are essential to any service delivering epilepsy 
care to people with ID, as opposed to those that are desirable. 
Minimum – where all psychiatrists are certified as Bronze
1 Services should support written care plans and emergency 
care plans.
2 Services should act as health advocates to support patients 
to access other specialist services for investigations and so 
on, if systems for these are already not in place. 
3 In cases of active or complex epilepsy, awareness and path-
ways need to be developed to identify outlets and referrals 
for second opinion if needed. 
4 All patients with epilepsy and ID should be identified, the 
team members to be involved selected and the source of 
medical support confirmed.
5 For all such patients, services need to know when a review 
is required and, together with primary care colleagues, make 
a re-referral to specialist services as needed.
6 From a research perspective, services could help identify and 
recruit to suitable studies.
What should services 
look like?
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7 All individuals should have an epilepsy risk assessment.
8 There should be at least annual audit to ensure that all 
patients have risk assessment, management plans are 
reviewed and a referral pathway is sought.
9 Services should be able to support relevant stakeholders, 
including carers, and hold best interests meetings relevant 
to managing complex epilepsy.
10 Services should support access to clinical investigations such 
as EEG and MRI. 
11 Services should be able to monitor their care delivery against 
NICE guidelines and outcome indicators.
12 Services should ensure that individuals with epilepsy and their 
families are informed and provided with educational materials.
13 Services should support rescue medication plans with training.
14 Services should be able to support seizure recording, night-time 
monitoring and risk reduction.
15 There should be availability of or referral to epilepsy-specific 
psychological support.
16 There should be availability of or referral to NEAD psychological 
support.
Where psychiatrists are certified as Silver and Gold, all of the above, 
plus:
1 Have the support of an ID nurse specialist with expertise in 
epilepsy or an epilepsy nurse specialist with competencies in ID.
2 Have clear defined links with specialist neurology services, 
depending on expertise. This should include access to coun-
selling on women’s health issues, referral for surgery, support of 
VNS, and access to further investigation such as prolonged EEG.
3 Have established links to medical genetics and expertise in refer-
ral for genetic assessment.
4 Be able to support patients in drug choice, advise on diagnosis 
and seizure risk, develop risk plans, prescribe rescue medication, 
educate on rescue medication.
5 Support prescription of AEDs, monitor outcomes and side-effects.
6 Support the diagnostic process.
7 Engage with other services to provide holistic and safe care, 
for example, managing a person with tuberous sclerosis and 
other genetic conditions with epilepsy phenotypes.
An adaptation of the Green Light Toolkit has been proposed for eval-
uation of service status. 
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Clinical vignettes 
This section uses examples to highlight:
 z the complexities of diagnosis of epilepsy in a person with ID
 z expectations for delivery of the proposed Bronze/Silver/Gold 
model of care.
Differential diagnosis of epilepsy
Clinical vignette 1
Johnny is a 24-year-old man with moderate ID and autism. He lives in 
a care home with other people with autism and challenging behaviour. 
He has lived in the home for the past 3 years. He has regular contact 
with his family; he has a brother who also has autism and has epilepsy. 
He has been referred as a result of a collapse in the street on the way 
to the shop. No physical cause for this collapse could be found. There 
is also a concern that Johnny has been talking to himself in his room. 
Staff have struggled to hear what he is saying, but he sometimes 
seems to have a strange voice when doing this. There has been a 
recent violent incident in the home. One of the residents attacked 
another and the staff had to intervene. One of the staff members 
was injured in this process and so the police were called. As a result 
of the level of concern, the police took one of the residents away for 
assessment, as they were concerned that the situation in the home 
was unsafe. Things are still a little unsettled. Johnny has been biting 
his lip as a repetitive behaviour, thought to be due to his increased 
levels of stress; blood has been noted on his pillow.
Johnny attends clinic with a carer. He sits quietly during the inter-
view twiddling a piece of string he has brought with him. Although 
approached, he does not answer questions; the staff member says 
this is not uncommon when he first meets a new person. He makes 
no eye contact. The member of staff that attends clinic today was, 
helpfully, the person that was with him when the event occurred. 
He explains that Johnny likes routine and that his normal routine 
has been a little disrupted owing to the incident with the police and 
the episode last week. He would normally have gone to a stable to 
help with mucking out on the day of the episode, but could not go 
as there was no driver that could take him there. In order to still offer 
him one-to-one time, the carer had explained to Johnny that there 
was no work as there was no driver and so, instead, they were going 
to go to the shop to do his personal shopping. They were walking to 
the shop when the event occurred.
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Johnny got dressed and put on his coat to go to the shop, seemingly 
without too much difficulty. When they left the house, he seemed to 
be compliant and happy, vocalising that they were going to the shop. 
There were some roadworks en route, and so they had to cross 
over and walk a slightly different route. While on the new route, they 
heard the siren of a passing emergency vehicle, but couldn’t work 
out what sort of emergency there was. Johnny stopped, seemed 
frozen, bit his lip, stared to one side, mumbled something to himself 
and then seemingly fell to the ground next to a car. While lying in the 
gutter, he seemed to have some ‘odd movements’, but these were 
not clearly tonic, clonic or coordinated. It did seem like his hands were 
‘scrunched up’. It was impossible to see his eyes as he was lying face 
down. He lay quite still for a number of minutes; the carer called for 
help, initially from the home. By the time another carer had arrived, 
Johnny was sitting up, seemed a little dazed and confused, had not 
been incontinent, had some blood coming from his lip and would 
not engage in conversation. They were able to make an emergency 
appointment with the GP. While in the waiting room, Johnny started 
talking under his breath while twiddling his string. The GP referred 
him to the community learning disability team (CLDT) for review.
In describing this case (you know that it is made up because the carer 
that attended was the carer who could give a first-hand account of the 
situation!) we have put together a number of possibilities in order to 
demonstrate the care that is required in trying to understand individual 
issues that may help with making the diagnosis.
1 Anxiety has a significant role in people with autism and in people 
with ID in general. Could Johnny be anxious about the changes 
that have taken place in the house? He might have a concern 
that the police have taken someone away and that he may be 
next. When he heard the siren, he thought they were coming 
for him and had a panic attack. His hands were ‘scrunched up’ 
owing to carpo-pedal spasm, and this is why he looked stiff in 
the gutter. It might also explain why he was dazed and confused 
afterwards.
2 Mental illness is more common in people with ID than in the 
general population. A diagnosis of schizophrenia is sixfold more 
likely. Johnny is 24 years old, an age at which psychosis may first 
appear. He has been talking to himself when there are no other 
people around. Has he been responding to voices? Could it be 
that he stopped on the walk because he was distracted, that the 
voices then said something that made him frightened and that 
he lay in the gutter to try to escape from them?
3 A significant feature of developmental disabilities is the need 
for routine. This is an important feature in the management of 
people with autism, in particular, but can be seen in all those 
with developmental disability. Adherence to routine makes the 
person feel safe and secure. The fact that Johnny was not able 
to attend his usual activity on the day would have made him a 
little irritated, as this was a deviation from his routine. The carer 
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explained to him that he wasn’t able to do his routine on that day 
and that they were going to the shop instead. He usually goes 
to the shop on a Thursday, and this was Tuesday, so he was a 
little uncertain about what was going to happen on Tuesday and 
whether he was going to the shop on Tuesday as well. Then, on 
the walk, they deviated from the usual path and so this meant 
that they were now not going to the shop at all. Could Johnny 
have sunk to his knees and lain in the gutter as a protest against 
all of the changes in his routine and the inadequate explanation 
for the changes and what these meant?
4 Physical illness, and particularly pain, can present differently in 
people with ID. Autistic people, in particular, may have a high 
pain threshold. Without thinking about the person as a whole 
and considering all of the options, sometimes physical illness 
can be overlooked. Could it be that Johnny had put on his shoe 
without first checking that it had nothing in it? During the melee 
the other day, a jug was broken and a shard of glass fell into 
Johnny’s shoe; he then put this on and went on his walk to the 
shop. He has a shard of glass in his foot that is causing him pain 
every time he walks on it and this has changed his behaviour. He 
fell to the ground as he was feeling faint from the pain associated 
with walking to the shop with this glass in his foot.
5 Epilepsy is common in people with ID and Johnny has a brother 
who has the diagnosis. He is therefore at risk of having seizures, 
and this diagnosis needs to be considered. It is important to 
piece together a ‘video’ of the even in one’s own mind, to try 
to understand whether the event described is more likely to be 
epilepsy than anything else. Eyes deviating to one side, a distant 
look with the person being ‘inaccessible’, repetitive movements 
(lip smacking or picking at clothing) and abnormal movements 
that are synchronous and a recovery period afterwards would 
make this more likely to be a seizure. Blood on the pillow is also a 
common sign of nocturnal seizures. Is there sufficient information 
in this history to consider that Johnny may have had a seizure?
Any one of these diagnoses is possible and should be thought through. 
It is very important to have a first-hand account of the event and to 
be able to piece together the whole story.
Epilepsy remains a clinical diagnosis that is based on a good history. 
The results of investigations, if negative, do not mean that this indi-
vidual does not have epilepsy. Equally, an EEG that is ‘abnormal’ but 
lacks the diagnostic spike waves is likely, so this result is potentially 
unhelpful. It is important to remain vigilant and to ensure that a good 
history is backed up by appropriate investigation and, if necessary, 
appropriate treatment.
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Modelling cases on to the 
proposed competency template 
Clinical vignette 2
An 18-year-old woman is transferred to the learning disability service 
from child and adolescent mental health services (CAMHS) for ongo-
ing assessment and treatment of her mixed problem behaviours. She 
has a diagnosis of mild ID, autism and epilepsy.
She has been taking one anti-epileptic medication since her epilepsy 
diagnosis, at a middle therapeutic dose. She has complex partial 
seizures (CPS) and generalised tonic–clonic seizures (GTCS) which 
require rescue oral medication after the first one in order to prevent 
clusters. She has an average of one seizure of either type each month. 
She lives with her parents and siblings.
ID epilepsy competencies for clinical vignette 2
Bronze
• Educate the patient if appropriate, according to capacity, regarding her epilepsy and medication 
management to enable her to more actively participate in the monitoring of her epilepsy and medication 
effectiveness and side-effects.
• Advocate for the patient with neurological and primary care services regarding her epilepsy needs.
• Ensure that the patient and her family have a clear description of her epilepsy and the risks associated with 
the diagnosis, have appropriate mitigating factors in place and know what to do in an emergency within 
their home. If this is not in place, support a referral to secondary care services in conjunction with primary 
care.
• Work with neurological and primary care services regarding the influence of the epilepsy or its treatment on 
the patient’s mixed problem behaviours.
Silver
• Attend paediatric neurology clinic as part of transition from child to adult services.
• Manage the epilepsy and its risks in conjunction with neurological services. This may include neurological 
services advising on and reviewing (at least every 6 months or sooner as deemed appropriate by the direct 
care team) the treatment plan, with the ID service undertaking treatment and risk management. Seek 
advice from neurological services if concerns arise between neurological appointments.
• Engage in discussion regarding more effective anti-epileptic management in terms of benefits and potential 
adverse effects.
• Ensure there are regular medical and nurse reviews regarding any medication changes, as well as reviews 
of the patient’s needs using the care programme approach.
Gold
• As for Silver, but assess and manage without neurological support and advice.
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Clinical vignette 3
A 45-year-old man with moderate ID and Down syndrome with whom 
the CLDT have been actively involved in the past year, assessing, diag-
nosing and supporting his residential home regarding his Alzheimer’s 
dementia, cognitive deterioration and behavioural disturbance.
He has a first GTCS and recovers within 3 minutes, but sleeps after-
wards. There is no personal or family history of epilepsy. He is refusing 
medications at the present time. He lives in supported living with 
24 h support.
ID epilepsy competencies for clinical vignette 3
Bronze
• Work jointly with primary care to refer the patient to neurological services for diagnosis and treatment.
• Work with neurological and primary care services regarding the influence of the epilepsy or its treatment on 
behavioural and psychological symptoms of dementia.
• Provide advice to neurological services regarding the patient’s capacity, the best interests process and 
decisions about medication, as the patient is currently refusing all medication.
• Ensure that the patient and the home have a clear description of his epilepsy and the risks associated with 
the diagnosis, have appropriate mitigating factors in place and know what to do in an emergency within the 
home. If this is not in place, support a referral to secondary care services in conjunction with primary care.
Silver
• As for Bronze, work jointly with primary care to refer the patient to neurological services for diagnosis and 
treatment.
• Actively manage the epilepsy and its risks following advice from neurological services.
• Refer back to neurological services if the epilepsy or the patient’s situation changes.
• Engage in discussion regarding more effective anti-epileptic management in terms of benefits and potential 
adverse effects.
• Ensure there are regular medical and nurse reviews regarding any medication changes, as well as reviews 
of the patient’s needs using the care programme approach.
Gold
• As for Silver, but assess, investigate, diagnose and decide on medication management within the 
community learning disability service, without support from neurology (except for seeking second opinion).
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Clinical vignette 4
A 40-year-old woman with severe ID has had a diagnosis of epilepsy 
since she was 3 years old. She suffers with multiple seizure types, 
which the home find difficult to accurately describe and differentiate 
– myoclonic, GTCS and CPS with secondary generalisation. She has 
at least one seizure a day according to the home.
In the past 2 years, she has suffered with two status epileptic episodes 
as a result of physical illness. She is taking valproate, lamotrigine and 
carbamazepine. The CLDT are involved as she has a deteriorating 
swallow and mobility. She lives in residential care.
ID epilepsy competencies for clinical vignette 4
Bronze
• Advocate for the patient with neurological and primary care services regarding her epilepsy needs.
• Attend neurology reviews to ensure there is a joined-up approach with the swallowing and mobility 
difficulties.
• Ensure that the patient and care staff have a clear description of her epilepsy and the risks associated with 
the diagnosis, have appropriate mitigating factors in place and know what to do in an emergency within the 
home. If this is not in place, support a referral to secondary care services in conjunction with primary care.
Silver
• Attend neurology clinics to agree epilepsy treatment and risk management. 
• Manage the epilepsy and its risks in conjunction with neurological services. This may involve neurological 
services advising on the treatment plan and reviewing 3–6 monthly, with the ID service undertaking the 
treatment plan and risk management on a daily basis. Seek advice from neurological services if concerns 
arise between neurological appointments.
• Engage in discussion regarding more effective anti-epileptic management in terms of benefits and potential 
adverse effects.
• Ensure there are regular medical and nurse reviews regarding any medication changes, as well as reviews 
of the patient’s needs using the care programme approach.
Gold
• As for Silver but assess and manage without neurological support or advice.
• At some point, a diagnosis of Dravet syndrome is suggested following a case-based presentation at an 
academic meeting. The ID team involvement would then be to:
 { refer to neurological services to confirm the diagnosis, and then to initiate tertiary specialist treatment 
after discontinuing the carbamazepine and lamotrigine
 { agree with neurology ongoing involvement of ID services – similar to Silver level.
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Mapping clinical vignettes to 
competencies
The case vignettes highlight how to identify competencies of ID psy-
chiatrists. However, relevant support services are also required to 
enable delivery of a good-quality service. Looking at competencies 
in a categorical way can provide a pathway for ID psychiatrists to 
move between competencies, keeping in mind what their local ser-
vices provide. The service level expectations to support each level of 
competency are highlighted below, using clinical vignette 2. 
Bronze ID epilepsy competency
A Bronze ID psychiatrist would review the patient in line with NICE 
guidelines as identified earlier. They would educate the patient and/
or carers and review the medications. Service clinicians would help 
in writing up a risk assessment and an epilepsy care plan. Finally, if 
the intervention needed an external professional, they would work in 
collaboration with neurology and GP services.
Silver ID epilepsy competency
A Silver ID psychiatrist may work in a team with a good understanding 
of NHS procedures for epilepsy management, and have back-up from 
the local neurology or specialist epilepsy service.
There might be an established epilepsy nurse or an ID nurse with 
epilepsy competencies in place to review the patients, who would be 
able to order appropriate investigations. The psychiatrist would be 
able to look at the patient’s epilepsy needs by working in conjunction 
with the neurology service to ensure that epilepsy is reviewed every 
6 months. They would undertake risk assessments and treatment 
plans. They would discuss whether only one epilepsy medication is 
needed, or whether they need to add an additional AED to control the 
seizures. They may liaise with the neurologist to see if any neurological 
investigations, such as MRI, computed tomography (CT) or EEG, need 
to be done. If the patient’s care is deemed to be complex enough, the 
patient would need to be on the care programme approach. 
Finally, if the epilepsy issues are complex, the psychiatrist could refer 
to a neurologist and discuss treatment options. 
Gold ID epilepsy competency
A Gold competent ID psychiatrist would be able to do all the assess-
ments expected at the Silver level; however, they would not require 
major input from neurology, and they would have the expertise to do 
all the investigations and management. They would provide a stand-
alone service which has its own expertise along with a supportive 




As epilepsy is a common medical condition, it is important that there 
are sufficient appropriately trained professionals to ensure that people 
with ID are well supported to have the best outcomes possible for 
this long-term condition.
When there are no clearly defined roles and responsibilities, there is a 
risk that we may succumb to the ‘bystander effect’ (Darley & Latané, 
1968). If no one has clear responsibility, each clinician involved thinks 
someone else is going to take charge of the situation and make the 
changes that are required. Epilepsy needs to be everyone’s business, 
and we need to be sure that there are people with the appropriate 
skills to manage the condition, who are able to recognise when they 
need additional support, and who know where they should refer 
more complex cases. 
There is significant variation in services across the UK (Robertson 
et al, 2015b). The best areas are those with well-defined and com-
prehensive services, where neurology and ID psychiatry have clear 
roles and responsibilities and an agreement on how to manage the 
workload; while some areas have a less clear arrangement but with 
clarity about which service has primacy in epilepsy management. 
Other areas have no clear pathway and an expectation that ‘others’ 
will manage the epilepsy rather than clarity of purpose.
The diversity of practice means that any future developments will 
be aspirational. It is important that the medical student curriculum 
includes adequate education on epilepsy diagnosis and management. 
It is also important to consider how the understanding of epilepsy 
and its management in primary care could be enhanced. There is 
a drive to ensure that, as part of the Directed Enhanced Service for 
primary care in England, epilepsy is reviewed by the GP and that 
there is a record in the health action plan as to whether the person 
is seen in primary care or secondary care for their epilepsy (and, if 
in secondary care, then a note as to whether this is the neurology 
service or the psychiatry service).
We can, of course, be far clearer about what should be in the 
curriculum for the training of psychiatrists. There are a number of 
opportunities for trainees. These can range from special-interest ses-
sions in a neurology or neuropsychiatric clinic to direct and hands-on 
management in a clinical setting. There are additional opportunities 
for teaching on the various MRCPsych courses. There is an ID curric-
ulum, which can include epilepsy management. This is an area that 
all psychiatrists of the future may benefit from. There are also formal 
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teaching opportunities for trainees through the ILAE, which has an 
annual conference and a biannual teaching weekend for trainees in 
neurology, paediatrics and psychiatry.
For consultants, there are similar opportunities, particularly the ILAE 
annual conference. There are often regional meetings on epilepsy, 
and it is important that consultants engage in ongoing CPD in epi-
lepsy in order to maintain their skill set. Although this has not been 
explicitly laid down in our model of competencies, each consultant 
should look at their case-load and agree, as part of their appraisal 
and job plan, what ongoing training they may need to maintain their 
Bronze, Silver or Gold ‘status’. 
It is important to recognise that each level will have its own set of 
competencies. There might be a consideration of how a psychiatrist 
evidences these sets of competencies for each domain. For other 
professionals who work in the epilepsy field, there are not only com-
petency frameworks but exams and accreditations. For example, 
epilepsy specialist nurses have medication prescriber courses and 
accreditation. Neurologists will have had basic epilepsy management 
training and validation for their Royal College of Physicians mem-
bership. Paediatricians have the Paediatric Epilepsy Training (PET) 
courses from the British Paediatric Neurology Association. It is also 
important that there are procedures in place to accredit those who 
move between levels, especially to a Silver or Gold level: these may 
involve standardised competency assessments, a semi-structured 
formative framework to be supported by peer groups or trainers, a 
minimum portfolio requirement, or all of these. Distance learning mod-
ules, either via the Royal College of Psychiatrists or other accredited 
bodies such as the ILAE, could be used to support the accreditation 
process. We suggest using the distance learning PET course (https://
www.bpna.org.uk/distancelearning/) as a model. In order to develop 
this type of module, experts in the field need to facilitate the process, 
ensuring that best practice and standards regarding epilepsy and 
General Medical Council (GMC) regulations are kept in mind. Until 
such an initiative is supported, the individual psychiatrist should ensure 
that they work within their domains of competency as stipulated by the 
GMC, look to develop skills and competencies with peer supervision 
from their CPD or peer group, and use the Core Knowledge, Skills 
and Attitudes Framework described in the next section. 
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This framework is modelled on the Learning Disabilities Core Skills 
Education and Training Framework, which was commissioned and 
funded by the Department of Health and developed in collaboration 
by Skills for Health, Skills for Care and Health Education England 
(Skills for Health, 2016), and may be read and utilised in conjunction 
with this document.
 z Knowledge, skills and attitudes for roles that require general awareness of 
epilepsy in people with an intellectual disability.
For example, medical students, orthopaedic surgeons.Bronze 
A
 z Knowledge, skills and attitudes for roles that will have regular contact with 
people with an intellectual disability and epilepsy. 
For example, general practitioners, psychiatry trainees in all specialities.Bronze 
B
 z Knowledge, skills and attitudes for those who are providing care and support 
for epilepsy in people with an intellectual disability.
For example, intellectual disability psychiatrists, neurologists, general 
practitioners managing the epilepsy.
Silver
 z Knowledge, skills and attitudes for those who are providing expert epilepsy 
care and support in people with an intellectual disability. 
For example, intellectual disability psychiatrists and neurologists who diagnose 
and manage complex epilepsy.
Gold
Core Knowledge, Skills 
and Attitudes Framework
Fig. 3 The Gold, Silver and Bronze levels of the Core Knowledge, Skills and Attitudes Framework. 
The Bronze level is divided into two subcategories, Bronze A and Bronze B, depending on the level of 
contact the professional is expected to have with people with intellectual disability.







Know what is meant by the term ‘intellectual disability’, common types, 
prevalence and causes
Know what is meant by the term ‘epilepsy’, common types, prevalence and 
causes
Be aware of the key legislation, policy and guidelines when working with 
people with an intellectual disability and epilepsy
Be able to communicate effectively with people with an intellectual disability, 
their families and carers
Know the importance of a person-centred approach and reasonable 
adjustments when working with people with an intellectual disability to 
maximise their quality of life, while minimising the effects of epilepsy and 
side-effects of treatment
Be aware of the prevalence of epilepsy in people with an intellectual 
disability and the impact on their lives, and how this differs from the general 
population with epilepsy
Be aware of the key legislation, policy and guidelines when working with 
people with an intellectual disability and epilepsy
Be able to communicate effectively with people with an intellectual disability, 
their families and carers
Know what health services are available and how to refer people with an 
intellectual disability to improve their biopsychosocial outcomes in relation to 
the epilepsy 
Devise and implement appropriate health action plans that meet the health 
needs of people with an intellectual disability and epilepsy
Understand the health inequalities experienced by people with an intellectual 
disability and epilepsy
Understand the complexity and comorbidity of epilepsy in people with an 
intellectual disability and support them to reduce health inequalities as a 
result of this complexity and comorbidity
Develop and disseminate health promotion advice to people with an 
intellectual disability, their families and carers in relation to epilepsy
Assess and manage risk related to epilepsy in people with an intellectual 
disability
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Take a history to gather information regarding whether the event is epileptic 
in nature, and if so the type of seizure, and differential diagnosis in people 
with an intellectual disability
Identify, order and interpret investigations as part of the assessment, 
diagnosis and treatment of epilepsy in people with an intellectual disability
Know the classification of seizures and be able to differentiate, through 
appropriate use of history taking and assessment tools, the type of seizure 
and syndrome
Know and be able to consider the link between the epilepsy syndrome and 
the aetiology of the intellectual disability in order to more effectively manage 
the person’s condition to improve their quality of life
Have a working, day-to-day knowledge of current national guidelines in 
relation to assessment and treatment of epilepsy
Be able to initiate, monitor and evaluate epilepsy treatment, including 
knowing the specific idiosyncratic effects in people with an intellectual 
disability and the need to take into account potential comorbidities such as 
dysphagia
Be able to initiate and evaluate appropriate rescue medication
Understand that people with an intellectual disability and epilepsy have 
greater health needs than the general population and are more likely to have 
respiratory disease, gastrointestinal reflux or osteoporosis which affects their 
epilepsy and treatment
Be able to fully involve the person with an intellectual disability and epilepsy 
in the process of understanding and devising supports relating to their 
epilepsy
Understand the important role families and carers have in supporting people 
with an intellectual disability and epilepsy and involve them appropriately in 
the care of the person
Understand and refer when the support of a ‘specialist in epilepsy’ might be 
needed
Be able to synthesise data to create a formulation for a person with an 
intellectual disability and epilepsy and devise appropriate care and support 
plans
Understand that epilepsy may develop and present in different ways in 
people with an intellectual disability, and that the usual signs or symptoms 
may not be observable or reportable
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